secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001842952-25-000024
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics receives Nasdaq minimum bid price deficiency notice
------------------------------------------------------------------------

- Received Nasdaq deficiency notice on Feb 27, 2025 for failing $1.00 minimum bid price for 30 consecutive business days.
- Initial 180-day cure period runs until August 26, 2025 to regain compliance.
- Must have closing bid price of $1.00+ for at least 10 consecutive business days to cure.
- Company will monitor and evaluate options, but no assurance of regaining compliance.
- If not cured by Aug 26, may be eligible for an additional 180-day grace period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295225000024/0001842952-25-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295225000024/cntx-20250227.htm
  HTML page:      https://secwatch.observer/filing/0001842952-25-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer